Cargando…

An Immunologic Storm: A Case of Encephalitis and Thrombotic Thrombocytopenic Purpura With Underlying Likely Sjogren’s Syndrome Induced by a COVID-19 Immune Response

INTRODUCTION: There are rare cases of Sjogren’s syndrome presenting with manifestations of encephalitis. There are also rare patients with Sjogren’s presenting with acute thrombotic thrombocytopenic purpura (TTP). There are no cases of both occurring together as the only symptoms of the syndrome. Du...

Descripción completa

Detalles Bibliográficos
Autores principales: Kasturiarachi, Brittany M., Alsbrook, Diana L., Crook, Jennifer, Shah, Namrata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919096/
https://www.ncbi.nlm.nih.gov/pubmed/35747766
http://dx.doi.org/10.1177/19418744221079447
_version_ 1784668878565015552
author Kasturiarachi, Brittany M.
Alsbrook, Diana L.
Crook, Jennifer
Shah, Namrata
author_facet Kasturiarachi, Brittany M.
Alsbrook, Diana L.
Crook, Jennifer
Shah, Namrata
author_sort Kasturiarachi, Brittany M.
collection PubMed
description INTRODUCTION: There are rare cases of Sjogren’s syndrome presenting with manifestations of encephalitis. There are also rare patients with Sjogren’s presenting with acute thrombotic thrombocytopenic purpura (TTP). There are no cases of both occurring together as the only symptoms of the syndrome. During the COVID-19 pandemic, more cases of autoimmunity are being described given its robust immune response. It is important to keep a wide differential about these varying clinical presentations. CASE PRESENTATION: Our patient is a 19-year-old female with a history of menorrhagia, recent COVID-19 infection, and remote suicidal ideation. She presented with headaches, vomiting, and psychosis. Her labs found platelets of 12,000 and she was soon discovered to have TTP. She was found to have contrast enhancing lesions scattered in her left hemisphere on magnetic resonance imaging as well as seizures. Her workup was negative for infection, but labs revealed a positive antinuclear antibody, elevated anti-Ro antibody (anti-SSA) and anti-La antibody (anti-SSB), and elevated COVID-19 antibodies. She was treated with antiepileptics, pulse dose steroids for 5 days, plasmapheresis, and weekly rituximab for 4 weeks. She had significant clinical improvement. CONCLUSION: Sjogren’s syndrome can have varying presentations including TTP with or without encephalitis as a presenting feature. Autoimmunity can also be triggered from COVID-19 infection.
format Online
Article
Text
id pubmed-8919096
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-89190962022-03-15 An Immunologic Storm: A Case of Encephalitis and Thrombotic Thrombocytopenic Purpura With Underlying Likely Sjogren’s Syndrome Induced by a COVID-19 Immune Response Kasturiarachi, Brittany M. Alsbrook, Diana L. Crook, Jennifer Shah, Namrata Neurohospitalist Case Reports INTRODUCTION: There are rare cases of Sjogren’s syndrome presenting with manifestations of encephalitis. There are also rare patients with Sjogren’s presenting with acute thrombotic thrombocytopenic purpura (TTP). There are no cases of both occurring together as the only symptoms of the syndrome. During the COVID-19 pandemic, more cases of autoimmunity are being described given its robust immune response. It is important to keep a wide differential about these varying clinical presentations. CASE PRESENTATION: Our patient is a 19-year-old female with a history of menorrhagia, recent COVID-19 infection, and remote suicidal ideation. She presented with headaches, vomiting, and psychosis. Her labs found platelets of 12,000 and she was soon discovered to have TTP. She was found to have contrast enhancing lesions scattered in her left hemisphere on magnetic resonance imaging as well as seizures. Her workup was negative for infection, but labs revealed a positive antinuclear antibody, elevated anti-Ro antibody (anti-SSA) and anti-La antibody (anti-SSB), and elevated COVID-19 antibodies. She was treated with antiepileptics, pulse dose steroids for 5 days, plasmapheresis, and weekly rituximab for 4 weeks. She had significant clinical improvement. CONCLUSION: Sjogren’s syndrome can have varying presentations including TTP with or without encephalitis as a presenting feature. Autoimmunity can also be triggered from COVID-19 infection. SAGE Publications 2022-03-11 2022-07 /pmc/articles/PMC8919096/ /pubmed/35747766 http://dx.doi.org/10.1177/19418744221079447 Text en © The Author(s) 2022
spellingShingle Case Reports
Kasturiarachi, Brittany M.
Alsbrook, Diana L.
Crook, Jennifer
Shah, Namrata
An Immunologic Storm: A Case of Encephalitis and Thrombotic Thrombocytopenic Purpura With Underlying Likely Sjogren’s Syndrome Induced by a COVID-19 Immune Response
title An Immunologic Storm: A Case of Encephalitis and Thrombotic Thrombocytopenic Purpura With Underlying Likely Sjogren’s Syndrome Induced by a COVID-19 Immune Response
title_full An Immunologic Storm: A Case of Encephalitis and Thrombotic Thrombocytopenic Purpura With Underlying Likely Sjogren’s Syndrome Induced by a COVID-19 Immune Response
title_fullStr An Immunologic Storm: A Case of Encephalitis and Thrombotic Thrombocytopenic Purpura With Underlying Likely Sjogren’s Syndrome Induced by a COVID-19 Immune Response
title_full_unstemmed An Immunologic Storm: A Case of Encephalitis and Thrombotic Thrombocytopenic Purpura With Underlying Likely Sjogren’s Syndrome Induced by a COVID-19 Immune Response
title_short An Immunologic Storm: A Case of Encephalitis and Thrombotic Thrombocytopenic Purpura With Underlying Likely Sjogren’s Syndrome Induced by a COVID-19 Immune Response
title_sort immunologic storm: a case of encephalitis and thrombotic thrombocytopenic purpura with underlying likely sjogren’s syndrome induced by a covid-19 immune response
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919096/
https://www.ncbi.nlm.nih.gov/pubmed/35747766
http://dx.doi.org/10.1177/19418744221079447
work_keys_str_mv AT kasturiarachibrittanym animmunologicstormacaseofencephalitisandthromboticthrombocytopenicpurpurawithunderlyinglikelysjogrenssyndromeinducedbyacovid19immuneresponse
AT alsbrookdianal animmunologicstormacaseofencephalitisandthromboticthrombocytopenicpurpurawithunderlyinglikelysjogrenssyndromeinducedbyacovid19immuneresponse
AT crookjennifer animmunologicstormacaseofencephalitisandthromboticthrombocytopenicpurpurawithunderlyinglikelysjogrenssyndromeinducedbyacovid19immuneresponse
AT shahnamrata animmunologicstormacaseofencephalitisandthromboticthrombocytopenicpurpurawithunderlyinglikelysjogrenssyndromeinducedbyacovid19immuneresponse
AT kasturiarachibrittanym immunologicstormacaseofencephalitisandthromboticthrombocytopenicpurpurawithunderlyinglikelysjogrenssyndromeinducedbyacovid19immuneresponse
AT alsbrookdianal immunologicstormacaseofencephalitisandthromboticthrombocytopenicpurpurawithunderlyinglikelysjogrenssyndromeinducedbyacovid19immuneresponse
AT crookjennifer immunologicstormacaseofencephalitisandthromboticthrombocytopenicpurpurawithunderlyinglikelysjogrenssyndromeinducedbyacovid19immuneresponse
AT shahnamrata immunologicstormacaseofencephalitisandthromboticthrombocytopenicpurpurawithunderlyinglikelysjogrenssyndromeinducedbyacovid19immuneresponse